The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Advertising (16)
- (-) Non-prescription medicines (9)
- Regulatory compliance (33)
- Therapeutic goods regulation (33)
- Medicine safety (29)
- Prescription medicines (27)
- Vaping hub (19)
- Legislation (15)
- Compliance and enforcement hub (13)
- Safety (12)
- Manufacturing (11)
- Complementary medicines (10)
- Australian Register of Therapeutic Goods (ARTG) (9)
- Import and export (8)
- Labelling and packaging (8)
- Listed medicines (8)
- Medical devices safety (8)
- Medicinal cannabis hub (6)
- Over the counter (OTC) medicines (6)
- Alert/Advisory (5)
- COVID-19 vaccines (5)
- Scheduling (national classification system) (5)
- COVID-19 (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Weight loss products (3)
- Advisory bodies and committees (2)
- Clinical trials (2)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Fees and payments (1)
- Registered complementary medicines (1)
- Shortages (1)
- Sunscreens (1)
Search
25 result(s) found, displaying 1 to 25
-
Safety updatesTCMs sold in Australia are carefully regulated to ensure safety and quality.
-
Media releasesWe have issued infringement notices totalling $37,560 for the alleged unlawful possession of a commercial quantity of vaping goods.
-
NoticesMRA GMP clearances that are expiring on 31 December 2024 will be automatically extended.
-
Safety updatesHealth professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.
-
Media releasesThe TGA has settled judicial review proceedings brought by InstantScripts in respect of infringement notices issued to it by the TGA.
-
NoticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) which commenced on 27 September 2024.
-
Media releasesThe TGA reminds businesses and media outlets that it is unlawful to publicly advertise prescription-only medicines, including prescription-only weight loss medicines.
-
NoticesInformation for manufacturers and sponsors regarding a new method for GMP inspections that will be used from 1 July 2024 and the extended validity of TGA issued GMP Certificates.
-
Media releasesInfringement notices were issued to businesses and individuals for the alleged unlawful advertising of prescription-only medicines on their websites.
-
Media releasesTGA has issued 3 infringement notices totalling $56,340 to News Life Media Pty Ltd for alleged unlawful advertising of medicinal cannabis on their popular lifestyle website Body+Soul.
-
Media releasesTGA has issued 35 infringement notices totalling $627,252 to 6 businesses and 2 individuals for the alleged unlawful advertising of medicinal cannabis on their websites and social media platforms.
-
Media releasesTGA has commenced proceedings in the Federal Court of Australia against Key Promotional Products Pty Ltd, and an individual, for allegedly importing and supplying unapproved rapid antigen test kits
-
NoticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024, which commenced on 14 June 2024.
-
Media releasesInfringement notices totalling $171,972 have been issued to Better Leaf Pty Ltd, and an individual, for the alleged unlawful advertising of medicinal cannabis on its website and social media.
-
Media releasesThe Dolphins National Rugby League club has worked with us, agreeing to remove Alternaleaf branding from its jerseys and on signages displayed at stadiums during its games.
-
NewsWe will adopt the 2021 Sunscreen Standard into therapeutic goods legislation. If you're a manufacturer or sponsor, find out what this means for you.
-
Media releasesIt is alleged the companies unlawfully advertised medicinal cannabis using terms including ‘medical cannabis’ and ‘plant medicine’, allowing patients to purchase prescription-only medicines after online consultation.
-
NewsThe Assessed listed medicine evidence guidelines have been updated, based on feedback, to aid sponsors in preparing their product applications.
-
Media releasesWe have updated our guidance on advertising cosmetic injectables to ensure advertising rules are applied consistently across all industries that deal with therapeutic goods.
-
NoticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2024.
-
Media releasesThe TGA has issued 4 infringement notices totalling $75,120 to Liquefy Health Pty Ltd for the alleged unlawful importation and advertising of unapproved complementary medicines.
-
Media releasesThe TGA has issued 13 infringement notices totalling $42,900 to a New South Wales-based individual for the alleged unlawful advertisement and supply of erectile dysfunction medicines.
-
Media releasesThe TGA has issued 18 infringement notices totalling $157,752 to Kilpatrick & Douglas Pty Ltd and two directors, for the alleged unlawful advertising of nicotine vapes
-
NewsOn 1 January 2024, as part of the reforms to the regulation of vaping products, the Advertising Permission for Nicotine was repealed.
-
Media releasesThe TGA with the assistance of NSW Police have seized 478 sport supplements containing potentially dangerous substances from a Sydney retail store.